Back to search results
NCT07373275

Adolescent Lifestyle Medicine Headache Study

Enrolling by Invitation
NAAges 14–18Interventional
MaineHealth
~50 participants
Updated 2026-05-06 on ClinicalTrials.gov
What's tested:Lifestyle Medicine Group Medical Visits

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Attendance
Measured over From enrollment to end of treatment at 3 months
+1 more outcome measured

Conditions

Headache, Migraine

Explore related trials

Migraine

Where it's being run

1 sites across 1 states
Maine1

Study leadership

  • Jennifer Dubail, M.D. · PRINCIPAL_INVESTIGATOR · MaineHealth
  • Helis Jason, M.D. · PRINCIPAL_INVESTIGATOR · MaineHealth

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

14-18 years old
Frequent episodic migraine headaches with our without aura (\>4 months)
Patient at MaineHealth Pediatric Neurology or MaineHealth Pediatrics Portland
Current High School Enrollment
English Speaking

Exclusion

Age \<14 year or \>18 years
Diagnosis of eating disorder or Autism Spectrum Disorder
PHQ-A scores of 20 or higher
Intractable/daily headache
Headache secondary to specific medical or neurological conditions (e.g. brain tumor, infection, trauma)
Increase in prophylactic headache medication 6 weeks prior to the onset of intervention

What this trial measures

  • AttendanceFrom enrollment to end of treatment at 3 months

    For this outcome, we will track how often participants attend the group meetings. There will be seven group meetings to attend, one per week. Attendance will be tracked at each meeting by group facilitators. We will calculate the overall percentage of attendance for each participant over the seven weeks and report the mean percentage. We anticipate \>75% attendance to be successful.

  • Headache Diary CompletionFrom enrollment to end of treatment at 3 months

    For this outcome, we will track how often participants attend the group meetings. There will be seven group meetings to attend, one per week. Attendance will be tracked at each meeting by group facilitators. We will calculate the overall percentage of attendance for each participant over the seven weeks and report the mean percentage. We anticipate \>75% attendance to be successful.